T lymphocyte responses in HIV-1 infection: implications for vaccine development (Q33711396)

28 July 2017

1 reference

title

T lymphocyte responses in HIV-1 infection: implications for vaccine development (English)

1 reference

28 July 2017

1 reference

Brander C

1

1 reference

28 July 2017

Walker BD

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Current Opinion in Immunology

28 July 2017

published in

1 reference

28 July 2017

volume

11

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

451-459

1 reference

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Mechanisms of MHC class I--restricted antigen processing

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Dramatic rise in plasma viremia after CD8( ) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

In vivo migration and function of transferred HIV-1-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Vigorous HIV-1-Specific CD4 T Cell Responses Associated with Control of Viremia

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

HIV-specific cytotoxic T lymphocytes in seropositive individuals

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509)

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cytotoxic T-cell responses to HIV-1 reverse transcriptase, integrase and protease

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Oligoclonal expansions of CD8( ) T cells in chronic HIV infection are antigen specific.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Functional genomics Double-stranded RNA poses puzzle

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2 signaling

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Genetic evaluation of suspected cases of transient HIV-1 infection of infants

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Quantification of CD8 T lymphocytes responsive to human immunodeficiency virus (HIV) peptide antigens in HIV-infected patients and seronegative persons at high risk for recent HIV exposure

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Reduction of HIV concentration during acute infection: independence from a specific immune response

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Nonsynonymous Mutations within the Human Immunodeficiency Virus Type 1 pl7 Gene Are Clustered to Sequences Binding to the Host Human Leukocyte Antigen Class I Molecules

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Mother‐Child Class I HLA Concordance Increases Perinatal Human Immunodeficiency Virus Type 1 Transmission

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Productive infection of neonatal CD8 T lymphocytes by HIV-1.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

B cells directly tolerize CD8( ) T cells

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Apoptosis of CD8 T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Nef Interacts with the μ Subunit of Clathrin Adaptor Complexes and Reveals a Cryptic Sorting Signal in MHC I Molecules

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Lack of Reactivation of Cytomegalovirus (CMV) Retinitis after Stopping CMV Maintenance Therapy in AIDS Patients with Sustained Elevations in CD4 T Cells in Response to Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Induction of Systemic and Mucosal Immune Responses to Human Immunodeficiency Virus Type 1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant via Intramuscular and Intranasal Routes

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIVmac251: Dependence on Route of Challenge Exposure

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Selection of Virus Variants and Emergence of Virus Escape Mutants after Immunization with an Epitope Vaccine

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cross-clade envelope glycoprotein 160-specific CD8 cytotoxic T lymphocyte responses in early HIV type 1 clade B infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Cytotoxic T Cells from Human Immunodeficiency Virus Type 2-Infected Patients Frequently Cross-React with Different Human Immunodeficiency Virus Type 1 Clades

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Induction of specific T-cell responses in HIV infection

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

A Pilot Clinical Trial of HIV Antigen-Pulsed Allogeneic and Autologous Dendritic Cell Therapy in HIV-Infected Patients

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016/S0952-7915(99)80076-4

7 January 2021

10.1016/S0952-7915(99)80076-4

Identifiers

DOI

1 reference

28 July 2017

1 reference